HUTCHMED (China) (HCM) Research & Development (2018 - 2021)

HUTCHMED (China) (HCM) has 4 years of Research & Development data on file, last reported at -$66.0 million in Q2 2021.

• On a quarterly basis, Research & Development fell 51.83% year-over-year to -$66.0 million in Q2 2021; TTM through Jun 2021 was -$197.0 million, a 37.9% decrease from a year earlier, with the FY2025 full-year figure at -$19.1 million, up 29.86% from the prior year.
• Research & Development for Q2 2021 stood at -$66.0 million, down from -$57.1 million in the prior quarter.
• Over the last five years, Research & Development for HCM reached as high as $88.7 million in Q2 2018 and fell as low as -$102.6 million in Q2 2019.
• Historically, Research & Development has averaged -$18.4 million across 4 years, with a median of -$31.0 million in 2019.
• On a YoY basis, Research & Development climbed as much as 216.11% in 2019 and fell as far as 247.29% in 2019.
• Year by year, Research & Development stood at $25.4 million in 2018, then slumped by 247.29% to -$37.5 million in 2019, then decreased by 16.04% to -$43.5 million in 2020, then tumbled by 51.83% to -$66.0 million in 2021.
• Per Business Quant data, the three most recent Research & Development figures were -$66.0 million in Q2 2021, -$57.1 million in Q1 2021, and -$43.5 million in Q2 2020.